• Home
  • Blog
  • Sanofi Flu Vaccine Products Will be Delayed in Release by 3-4 Weeks

Sanofi Flu Vaccine Products Will be Delayed in Release by 3-4 Weeks

Written by
NMS Flu Team
Published on
July 15, 2019 at 12:54:00 PM PDT July 15, 2019 at 12:54:00 PM PDTth, July 15, 2019 at 12:54:00 PM PDT

Due to the delays by the World Health Organization (WHO) in finalizing the strains to be utilized in the 2019 influenza vaccine, Sanofi has said there will be delays in releasing their flu vaccine this year by 3-4 weeks.

Here is an excerpt of the Sanofi communication:

Each year, the World Health Organization (WHO) and U.S. Food and Drug Administration (FDA), with help from epidemiologists around the world, select the virus strains to be included in influenza vaccines for the upcoming season. This year, due to late-emerging A/H3N2 viruses that circulated globally, the WHO and FDA decided to delay selection of the A/H3N2 strain by one month. This allowed health authorities to collect additional data to help improve the match of the vaccine strain to the A/H3N2 strain anticipated to circulate during the 2019-2020 season.

Sanofi Pasteur fully supports this decision by health authorities to collect additional data and make a more informed selection. However, as a result of the delay we anticipate that delivery of our influenza vaccines will be approximately 3-4 weeks behind the shipping commitments previously communicated. Sanofi Pasteur fully expects to manufacture and deliver every dose reserved by our customers, beginning with partial shipments to all customers in late-August or September, with all shipments completed by the end of November.

At NMS we believe in sharing information wherever and whenever possible so that patient care is not compromised. It might make sense to change which vaccine you choose to administer this year given the delays.

Please reach out to us to advise if you wish to make any changes to your order.